Fasoracetam, a member of the racetam family, presents a unique approach to addressing cognitive challenges, particularly Attention Deficit Hyperactivity Disorder (ADHD). Its distinctive mechanisms involve enhancing GABA-B receptor sensitivity and modulating metabotropic glutamate receptors (mGluRs), setting it apart from traditional stimulant medications.
